Novel targeted treatment shows efficacy in treating high-risk solid tumours
The prodrug developed by researchers caused long-term remission in all murine models of high-risk or drug-resistant cancers with fewer side-effects than a comparable drug.
List view / Grid view
The prodrug developed by researchers caused long-term remission in all murine models of high-risk or drug-resistant cancers with fewer side-effects than a comparable drug.
A study has demonstrated that blocking certain receptors in mice reduced Ewing sarcoma growth and metastasis, which could be used within future treatments.
30 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Used for the first time as part of the team's latest work, the model may become a valuable experimental tool to analyse metastatic potential in sarcomas...